Biochemical and Biophysical Research Communications
Regular ArticleIdentification and Regulation of Human PDE5A Gene Promoter☆
References (27)
- et al.
Pulmonary Pharmacol. Therapeutics
(1999) J. Am. Coll. Cardiol.
(1999)- et al.
J. Biol. Chem.
(1993) - et al.
J. Urol.
(1998) - et al.
J. Biol. Chemi.
(1999) - et al.
Biochem. Biophys. Res. Commun.
(2000) - et al.
Biochem. Biophys. Res. Commun.
(2000) - et al.
DNA Cell Biol.
(1997) - et al.
Methods Enzymol.
(1980) - et al.
Biochem. Biophys. Res. Commun.
(1998)
Gene
J. Biol. Chem.
J. Biol. Chem.
Cited by (64)
Effect of Genetic Polymorphism on the Response to PDE5 Inhibitors in Patients With Erectile Dysfunction: A Systematic Review and a Critical Appraisal
2020, Sexual Medicine ReviewsCitation Excerpt :Thus, T786 C polymorphism at the eNOS locus appeared to be a major contributor in the variable erectile function PDE5Is/testosterone response. The PDE5A gene and its promoter regions have been sequenced and the functional regions are well described in humans.33,34 The presence of polymorphisms in PDE5A in humans has been linked to the reduced response to NO and altered levels of cGMP.35
Role of cyclic nucleotides and their downstream signaling cascades in memory function: Being at the right time at the right spot
2020, Neuroscience and Biobehavioral ReviewsDysregulated NO/PDE5 signaling in the sickle cell mouse lower urinary tract: Reversal by oral nitrate therapy
2019, Life SciencesCitation Excerpt :Decreased PDE5 activity in the urethra of Sickle mice is also evidenced by heightened urethral relaxation to an NO donor SNP (because the NO effector, cGMP, cannot be degraded). Low PDE5 activity is conceivably due to low NO bioavailability and absence of the cGMP-dependent feedback mechanism for PDE5 regulation [47,48]. A previous study described reduced protein expression of PDE5 in the bladder of male rats following bladder outlet obstruction-induced bladder overactivity, which has been speculated to be an adaptive response to decreased levels of cGMP; however, no functional relevance was suggested [49].
Genetics of NO Deficiency
2017, American Journal of CardiologyCitation Excerpt :PDE5 is expressed in smooth muscle cells and is the pharmacologic target of vasodilatory drugs (such as PDE5 inhibitors) used to treat PH and erectile dysfunction.54 The coding sequence, functional regions, and transcript variants of PDE5A are well described.55,56 Genetic studies have identified PDE5A variants associated with PH and chronic heart failure.
PDE5A Polymorphisms Influence on Sildenafil Treatment Success
2016, Journal of Sexual MedicineTranslational Perspective on the Role of Testosterone in Sexual Function and Dysfunction
2016, Journal of Sexual Medicine
- ☆
Abbreviations used: PDE, phosphodiesterase; PCR, polymerase chain reaction; db-cAMP, dibutyryl cyclic AMP; db-cGMP, dibutyryl cyclic GMP; AR, androgen receptor; bp, base pairs; kb, kilobases.